Abstract:ABSTRACT The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the pandemic and post-pandemic periods has been characterized by rapid adaptive changes that confer immune escape and enhanced human-to-human transmissibility. Sequence change is additionally marked by an excess number of C→U transitions suggested as being due to host-mediated genome editing. To investigate how these influence the evolutionary trajectory of SARS-CoV-2, 2,000 high-quality, coding complete genome sequences of SARS-CoV-2 variants collected pre-September 2020 and from each subsequently appearing alpha, delta, BA.1, BA.2, BA.5, XBB, EG, HK, and JN.1 lineages were downloaded from NCBI Virus in April 2024. C→U transitions were the most common substitution during the diversification of SARS-CoV-2 lineages over the 4-year observation period. A net loss of C bases and accumulation of U’s occurred at a constant rate of approximately 0.2%–0.25%/decade. C→U transitions occurred in over a quarter of all sites with a C (26.5%; range 20.0%–37.2%) around five times more than observed for the other transitions (5.3%–6.8%). In contrast to an approximately random distribution of other transitions across the genome, most C→U substitutions occurred at statistically preferred sites in each lineage. However, only the most C→U polymorphic sites showed evidence for a preferred 5′U context previously associated with APOBEC 3A editing. There was a similarly weak preference for unpaired bases suggesting much less stringent targeting of RNA than mediated by A3 deaminases in DNA editing. Future functional studies are required to determine editing preferences, impacts on replication fitness in vivo of SARS-CoV-2 and other RNA viruses, and impact on host tropism. IMPORTANCE Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the pandemic and post-pandemic periods has shown a remarkable capacity to adapt and evade human immune responses and increase its human-to-human transmissibility. The genome of SARS-CoV-2 is also increasingly scarred by the effects of multiple C→U mutations from host genome editing as a cellular defense mechanism akin to restriction factors for retroviruses. Through the analysis of large data sets of SARS-CoV-2 isolate sequences collected throughout the pandemic period and beyond, we show that C→U transitions have driven a base compositional change over time amounting to a net loss of C bases and accumulation of U’s at a rate of approximately 0.2%–0.25%/decade. Most C→U substitutions occurred in the absence of the preferred upstream-base context or targeting of unpaired RNA bases previously associated with the host RNA editing protein, APOBEC 3A. The analyses provide a series of testable hypotheses that can be experimentally investigated in the future.

Evidence for selection on SARS-CoV-2 RNA translation revealed by the evolutionary dynamics of mutations in UTRs and CDSs

Analysis of the mutation dynamics of SARS-CoV-2 reveals the spread history and emergence of RBD mutant with lower ACE2 binding affinity

Host-dependent C-to-U RNA editing in SARS-CoV-2 creates novel viral genes with optimized expressibility

Genome-wide mutation frequency variation among SARS-CoV-2 variants and its effects on the untranslated regions

Functional alterations caused by mutations reflect evolutionary trends of SARS-CoV-2

Snapshot of the Evolution and Mutation Patterns of SARS-CoV-2.

Phylogenetic signatures reveal multilevel selection and fitness costs in SARS-CoV-2

Host Immune Response Driving SARS-CoV-2 Evolution

Functional evolution of SARS-COV-2 Spike protein: adaptation on translation and infection via surface charge of spike protein

Translation landscape of SARS-CoV-2 noncanonical subgenomic RNAs

Enhanced detection and molecular modeling of adaptive mutations in SARS-CoV-2 coding and non-coding regions using the c/μ test

An in-silico study on SARS-CoV-2: Its compatibility with human tRNA pool, and the polymorphism arising in a single lineage over a month

C→U transition biases in SARS-CoV-2: still rampant 4 years from the start of the COVID-19 pandemic

Prediction of the effects of the top 10 synonymous mutations from 26645 SARS-CoV-2 genomes of early pandemic phase

Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets

Worldwide tracing of mutations and the evolutionary dynamics of SARS CoV 2

C->U transition biases in SARS-CoV-2 – still rampant four years from the start of the COVID-19 pandemic

SARS-CoV-2 Displays a Suboptimal Codon Usage Bias for Efficient Translation in Human Cells Diverted by Hijacking the tRNA Epitranscriptome

Decoding the genome of SARS-CoV-2: a pathway to drug development through translation inhibition

Review of the mechanisms of SARS-CoV-2 evolution and transmission

Properties and Mechanisms of Deletions, Insertions, and Substitutions in the Evolutionary History of SARS-CoV-2